Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct 11:7:20.
doi: 10.4103/1742-6413.70966.

The spectrum of coincident entities with small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) diagnosed by cytology

Hannah A Kastenbaum  1 , Walid E Khalbuss, Raymond E Felgar, Ronald Stoller, Sara E Monaco
Affiliations

The spectrum of coincident entities with small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) diagnosed by cytology

Hannah A Kastenbaum et al. Cytojournal. .

Abstract

Background: The cytologic diagnosis of Small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) often relies on finding a small lymphoid population with the characteristic immunoprofile by ancillary testing. There are only a few reports of other processes identified with SLL/CLL. The aim of this study was to review the fine needle aspiration (FNA) and touch prep (TP) diagnoses of SLL/CLL in order to identify any coincident entities.

Materials and methods: We retrospectively reviewed all FNA and TP cytology cases between January 2005 and May 2009 with a diagnosis of SLL/CLL to determine the presence of any coincident process.

Results: We identified 29 cases, including 23 FNAs and six TPs, from 23 patients. Ancillary studies were utilized in 97% of the cases, including flow cytometry (FC, 79%), immunohistochemistry (IHC, 55%), fluorescent in situ hybridization studies (24%) and special stains (7%). Coincident entities were identified in nine cases (31%) and included seven (28%) neoplastic entities (Hodgkin lymphoma [HL], adenocarcinoma, squamous cell carcinoma, seminoma) and two (7%) non-neoplastic entities (infection and immunoglobulin containing cells). Six cases (21%) suspicious for large cell transformation were also identified.

Conclusion: In our review of SLL/CLL, coincident entities were present in 31% of the cases and included a spectrum of non-neoplastic and neoplastic processes. FC was the most frequently utilized ancillary test, but IHC provided important information by excluding a mantle cell lymphoma or confirming a coincident process. Thus, cytomorphologic evaluation in these patients is important due to the high risk of a coincident process that may not be apparent by FC alone and may require clinical management.

Keywords: Chronic lymphocytic leukemia; SLL/CLL; cytopathology; small lymphocytic lymphoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mycobacterial infection involving a lymph node involved with SLL/CLL. A&B. In a background of lymphoma, the FNA showed histocytes (a. arrow) and granulomas b) with the negative image of mycobacteria on DQ stained smears (A. DQ, ×400; B. DQ, ×600). c) An AFB stain performed was positive for acid fast bacilli (AFB, ×400)
Figure 2
Figure 2
Immunoglobulin-rich histiocytic cells (crystal storage histiocytosis) in a lymph node involved with SLL/CLL. The touch prep of a mediastinal LN demonstrated histiocytic cells with abundant cytoplasm containing dense material and cracking in a background of monomorphic lymphocytes. The corresponding histology (inset) of the LN showed SLL/CLL with similar cells containing immunoglobulin, as confirmed by immunohistochemical stains (TP, hematoxylin and eosin [H&E], ×400; inset, histology, H&E, ×400)
Figure 3
Figure 3
Non-lymphoid malignancies with SLL/CLL. a) Squamous cell carcinoma with SLL/CLL in a LN (fine needle aspiration, Diff-Quik™ [DQ], ×600). b) Adenocarcinoma of the lung with parenchymal lung involvement by SLL/CLL (touch prep [TP], hematoxylin and eosin [H&E], ×400; inset, corresponding histology, H&E, ×400), c) anaplastic seminoma with SLL/CLL in a mediastinal LN (TP, DQ, ×400; inset, corresponding histology, H&E, ×400)
Figure 4
Figure 4
Hodgkin lymphoma arising in a background of SLL/CLL. a) The LN demonstrated several Reed-Sternberg cells (arrow) in a background of a small homogeneous lymphoid population with scattered eosinophils (arrowhead) (Diff-Quik™ [DQ], ×400). b) Immunostains confirmed the impression of Hodgkin’s lymphoma (CD30 immunostain, X200) and FC confirmed the presence of SLL/CLL. c) Histology of LN involved by HL and SLL/CLL (hematoxylin and eosin, X200)
Figure 5
Figure 5
Cytomorphology of SLL/CLL case with large cells suspicious for transformation and histologic follow-up. a) Fine needle aspiration of right axillary LN with large cells suspicious for transformation (Diff-Quik™, × 400). The large cells are approximately 2–2.5× the size of the adjacent red blood cells, with prominent large nucleoli, in a background of the small lymphoid cells characteristic of SLL/CLL. b) The follow-up bone marrow biopsy (hematoxylin and eosin, ×400) was involved by SLL/CLL and also showed large cells with similar features, which were worrisome for an incipient transformation. The peripheral blood also showed an increase in prolymphocytes
See this image and copyright information in PMC

References

    1. Dey P. Role of ancillary techniques in diagnosing and subclassifying non-Hodgkin’s lymphomas on fine needle aspiration cytology. Cytopathology. 2006;17:275–87. - PubMed
    1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008. Introduction to the WHO classification of tumours of haematopoietic and lymphoid tissues; pp. 14–5.
    1. Monaco SE, Teot LA, Felgar R, Surti U, Cai G. Fluorescence in-situ hybridization (FISH) studies on direct smears: an approach to enhance the fine needle aspiration biopsy diagnosis of B-cell non-hodgkin lymphomas. Cancer Cytopathology. 2009;117:338–48. - PubMed
    1. Abbott B. Chronic Lymphocytic leukemia: recent advances in diagnosis and treatment. Oncologist. 2006;11:21–30. - PubMed
    1. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111:5446–56. - PMC - PubMed